Vivaldi Capital Management LP Uro Gen Pharma Ltd. Transaction History
Vivaldi Capital Management LP
- $609 Million
- Q1 2025
A detailed history of Vivaldi Capital Management LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Vivaldi Capital Management LP holds 20,124 shares of URGN stock, worth $160,992. This represents 0.04% of its overall portfolio holdings.
Number of Shares
20,124
Previous 20,124
-0.0%
Holding current value
$160,992
Previous $214,000
3.74%
% of portfolio
0.04%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
38.7MCall Options Held
91.4KPut Options Held
42.1K-
Rtw Investments, LP New York, NY3.83MShares$30.7 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$25.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$18.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$17.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$17.2 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $182M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...